JPS5041859A - - Google Patents

Info

Publication number
JPS5041859A
JPS5041859A JP49085967A JP8596774A JPS5041859A JP S5041859 A JPS5041859 A JP S5041859A JP 49085967 A JP49085967 A JP 49085967A JP 8596774 A JP8596774 A JP 8596774A JP S5041859 A JPS5041859 A JP S5041859A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP49085967A
Other languages
Japanese (ja)
Other versions
JPS5761035B2 (cg-RX-API-DMAC7.html
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS5041859A publication Critical patent/JPS5041859A/ja
Publication of JPS5761035B2 publication Critical patent/JPS5761035B2/ja
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6536Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
    • C07F9/6539Five-membered rings
    • C07F9/6541Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503Five-membered rings
    • C07F9/6506Five-membered rings having the nitrogen atoms in positions 1 and 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503Five-membered rings
    • C07F9/6506Five-membered rings having the nitrogen atoms in positions 1 and 3
    • C07F9/65068Five-membered rings having the nitrogen atoms in positions 1 and 3 condensed with carbocyclic rings or carbocyclic ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6536Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
    • C07F9/6539Five-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP49085967A 1973-08-01 1974-07-26 Expired JPS5761035B2 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US384666A US3883546A (en) 1973-08-01 1973-08-01 S-heterocyclic derivatives of phosphine or phosphite gold mercaptides

Publications (2)

Publication Number Publication Date
JPS5041859A true JPS5041859A (cg-RX-API-DMAC7.html) 1975-04-16
JPS5761035B2 JPS5761035B2 (cg-RX-API-DMAC7.html) 1982-12-22

Family

ID=23518252

Family Applications (1)

Application Number Title Priority Date Filing Date
JP49085967A Expired JPS5761035B2 (cg-RX-API-DMAC7.html) 1973-08-01 1974-07-26

Country Status (9)

Country Link
US (1) US3883546A (cg-RX-API-DMAC7.html)
JP (1) JPS5761035B2 (cg-RX-API-DMAC7.html)
BE (1) BE818218A (cg-RX-API-DMAC7.html)
CA (1) CA1054609A (cg-RX-API-DMAC7.html)
DE (1) DE2437147C2 (cg-RX-API-DMAC7.html)
FR (1) FR2240014B1 (cg-RX-API-DMAC7.html)
GB (1) GB1422899A (cg-RX-API-DMAC7.html)
SE (1) SE7409800L (cg-RX-API-DMAC7.html)
ZA (1) ZA744598B (cg-RX-API-DMAC7.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017519817A (ja) * 2014-05-28 2017-07-20 オースフェリクス・リミテッドAuspherix Limited 抗菌薬としての金(i)−ホスフィン化合物
JP2017529357A (ja) * 2014-05-28 2017-10-05 オースフェリクス・リミテッドAuspherix Limited 抗菌薬としての金(i)−ホスフィン化合物

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4165380A (en) * 1977-02-25 1979-08-21 Smithkline Corporation Bis(sulfide)gold(1+) salts
US4172833A (en) * 1978-03-20 1979-10-30 R. T. Vanderbilt Company, Inc. Process for preparation of 2-mercaptotoluimidazole and salts thereof
EP0153307A4 (en) * 1983-08-10 1987-03-12 Richard F Stockel USE OF SELENIUM-CONTAINING COMPOUNDS TO PREVENT THE TOXIC EFFECTS OF GOLD COMPOUNDS USED IN THE TREATMENT OF RHEUMATOID ARTHRITIS, AND A NEW SELENIUM-CONTAINING GOLD COMPOUND AND THE USE THEREOF ASEM.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL131206C (cg-RX-API-DMAC7.html) * 1965-09-03
US3755329A (en) * 1970-12-22 1973-08-28 Du Pont Nitrogen-heterocyclylgold(i) compounds

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017519817A (ja) * 2014-05-28 2017-07-20 オースフェリクス・リミテッドAuspherix Limited 抗菌薬としての金(i)−ホスフィン化合物
JP2017529357A (ja) * 2014-05-28 2017-10-05 オースフェリクス・リミテッドAuspherix Limited 抗菌薬としての金(i)−ホスフィン化合物

Also Published As

Publication number Publication date
ZA744598B (en) 1975-07-30
JPS5761035B2 (cg-RX-API-DMAC7.html) 1982-12-22
AU7180774A (en) 1976-02-05
FR2240014B1 (cg-RX-API-DMAC7.html) 1978-07-21
BE818218A (fr) 1975-01-29
CA1054609A (en) 1979-05-15
DE2437147C2 (de) 1983-03-03
FR2240014A1 (cg-RX-API-DMAC7.html) 1975-03-07
SE7409800L (cg-RX-API-DMAC7.html) 1975-02-03
GB1422899A (en) 1976-01-28
US3883546A (en) 1975-05-13
DE2437147A1 (de) 1975-02-13

Similar Documents

Publication Publication Date Title
AR201758A1 (cg-RX-API-DMAC7.html)
AU476761B2 (cg-RX-API-DMAC7.html)
AU465372B2 (cg-RX-API-DMAC7.html)
AR201235Q (cg-RX-API-DMAC7.html)
AR201231Q (cg-RX-API-DMAC7.html)
AU474593B2 (cg-RX-API-DMAC7.html)
AU474511B2 (cg-RX-API-DMAC7.html)
AU474838B2 (cg-RX-API-DMAC7.html)
AU471343B2 (cg-RX-API-DMAC7.html)
AU465453B2 (cg-RX-API-DMAC7.html)
AU465434B2 (cg-RX-API-DMAC7.html)
AU450229B2 (cg-RX-API-DMAC7.html)
AU476714B2 (cg-RX-API-DMAC7.html)
AR201229Q (cg-RX-API-DMAC7.html)
AU466283B2 (cg-RX-API-DMAC7.html)
AU476696B2 (cg-RX-API-DMAC7.html)
AU472848B2 (cg-RX-API-DMAC7.html)
AR199451A1 (cg-RX-API-DMAC7.html)
AU477823B2 (cg-RX-API-DMAC7.html)
AR201432A1 (cg-RX-API-DMAC7.html)
AU471461B2 (cg-RX-API-DMAC7.html)
AR200885A1 (cg-RX-API-DMAC7.html)
AR200256A1 (cg-RX-API-DMAC7.html)
AR210729A1 (cg-RX-API-DMAC7.html)
AU476873B1 (cg-RX-API-DMAC7.html)